Ratio Revelations: Integra Lifesciences Holdings Corp (IART)’s Financial Metrics in the Spotlight

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

Integra Lifesciences Holdings Corp (NASDAQ: IART) closed the day trading at $23.14 down -19.90% from the previous closing price of $28.89. In other words, the price has decreased by -$19.90 from its previous closing price. On the day, 6.17 million shares were traded. IART stock price reached its highest trading level at $29.74 during the session, while it also had its lowest trading level at $22.36.

Ratios:

For a better understanding of IART, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.76. For the most recent quarter (mrq), Quick Ratio is recorded 2.18 and its Current Ratio is at 3.45. In the meantime, Its Debt-to-Equity ratio is 1.06 whereas as Long-Term Debt/Eq ratio is at 1.04.

On December 05, 2023, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $40 to $49.

On November 14, 2023, CL King started tracking the stock assigning a Buy rating and target price of $50.CL King initiated its Buy rating on November 14, 2023, with a $50 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 06 ’24 when DAVIS ROBERT T. JR. sold 8,348 shares for $36.59 per share. The transaction valued at 305,492 led to the insider holds 49,893 shares of the business.

Mosebrook Jeffrey sold 1,177 shares of IART for $52,329 on Aug 09 ’23. The SVP, Fin & PAO now owns 23,458 shares after completing the transaction at $44.46 per share. On Jun 01 ’23, another insider, De Witte Jan, who serves as the President & CEO of the company, bought 7,792 shares for $38.50 each. As a result, the insider paid 299,986 and bolstered with 12,798 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IART now has a Market Capitalization of 2272782848 and an Enterprise Value of 3634184448. As of this moment, Integra’s Price-to-Earnings (P/E) ratio for their current fiscal year is 27.44, and their Forward P/E ratio for the next fiscal year is 6.60. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.12. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.17 while its Price-to-Book (P/B) ratio in mrq is 1.14. Its current Enterprise Value per Revenue stands at 2.357 whereas that against EBITDA is 9.475.

Stock Price History:

Over the past 52 weeks, IART has reached a high of $51.12, while it has fallen to a 52-week low of $27.18. The 50-Day Moving Average of the stock is -31.81%, while the 200-Day Moving Average is calculated to be -41.05%.

Shares Statistics:

Over the past 3-months, IART traded about 800.68K shares per day on average, while over the past 10 days, IART traded about 970490 shares per day. A total of 78.17M shares are outstanding, with a floating share count of 66.21M. Insiders hold about 15.36% of the company’s shares, while institutions hold 84.97% stake in the company. Shares short for IART as of 1713139200 were 2614039 with a Short Ratio of 3.26, compared to 1710460800 on 2213188. Therefore, it implies a Short% of Shares Outstanding of 2614039 and a Short% of Float of 3.85.

Most Popular

[the_ad id="945"]